Metabolic Syndrome: A Narrative Review from the Oxidative Stress to the Management of Related Diseases.
Giovanni MartemucciGiuseppe FracchiollaMarilena MuragliaRoberta TardugnoRoberta Savina DibenedettoAngela Gabriella D'AlessandroPublished in: Antioxidants (Basel, Switzerland) (2023)
Metabolic syndrome (MS) is a growing disorder affecting thousands of people worldwide, especially in industrialised countries, increasing mortality. Oxidative stress, hyperglycaemia, insulin resistance, inflammation, dysbiosis, abdominal obesity, atherogenic dyslipidaemia and hypertension are important factors linked to MS clusters of different pathologies, such as diabesity, cardiovascular diseases and neurological disorders. All biochemical changes observed in MS, such as dysregulation in the glucose and lipid metabolism, immune response, endothelial cell function and intestinal microbiota, promote pathological bridges between metabolic syndrome, diabesity and cardiovascular and neurodegenerative disorders. This review aims to summarise metabolic syndrome's involvement in diabesity and highlight the link between MS and cardiovascular and neurological diseases. A better understanding of MS could promote a novel strategic approach to reduce MS comorbidities.
Keyphrases
- metabolic syndrome
- insulin resistance
- mass spectrometry
- oxidative stress
- multiple sclerosis
- ms ms
- uric acid
- immune response
- cardiovascular risk factors
- cardiovascular disease
- type diabetes
- high fat diet induced
- blood pressure
- high fat diet
- polycystic ovary syndrome
- dendritic cells
- ischemia reperfusion injury
- endothelial cells
- physical activity
- induced apoptosis
- weight gain
- endoplasmic reticulum stress
- signaling pathway
- drug induced
- inflammatory response
- diabetic rats